Pyridinolcarbamate and experimental atherosclerosis correlation of hypocholesterolemic and antiatherogenic effects
- 1 October 1978
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 31 (2) , 205-215
- https://doi.org/10.1016/0021-9150(78)90166-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Anti-inflammatory drugs in experimental atherosclerosis Part 1. Relative potencies for inhibiting plaque formationAtherosclerosis, 1973
- Enzyme histochemical observations on the effect of pyridinol carbamate on cholesterol-induced atherosclerosisAtherosclerosis, 1972
- The effects of pyridinolcarbamate on induced atherosclerosis in cynomolgus monkeys (Macaca ira)Atherosclerosis, 1972
- Dietary inhibition of experimental atherosclerosis in rabbits by 2-ethyl-n-caproic acidJournal of Atherosclerosis Research, 1969
- Prevention of experimental atherosclerosis with pyridinolcarbamateAmerican Heart Journal, 1969
- THE EFFECT OF DIETARY FAT LOAD ON THE SIZE AND COMPOSITION OF CHYLOMICRONS IN THORACIC DUCT LYMPHQuarterly Journal of Experimental Physiology and Cognate Medical Sciences, 1968
- The effect of pyridinolcarbamate on aortic and coronary atherosclerosis in squirrel monkeys(Saimiri sciurea)Journal of Atherosclerosis Research, 1968
- Pyridinolcarbamate, a bradykinin antagonist in veins: A preliminary report on pharmacologic and clinical observationsAmerican Heart Journal, 1966
- Atherosclerosis-inhibiting effect of an antibradykinin agent, pyridinolcarbamateAmerican Heart Journal, 1966
- The relationship of edematous reaction in arteries to atherosclerosis and thrombosisJournal of Atherosclerosis Research, 1963